Current Edition

FDA Issues Guidance on Reporting Requirements for Web-Based Promotion of Drugs and Biologics

The FDA has finally given some guidance on what drug companies must do to comply with federal reporting requirements when marketing their products through social media websites and other interactive media. Nick Nelson of Haynes and Boone LLP summarises this new and long-awaited guidance from the FDA.